Skip to the answer

Carvedilol

Carvedilol is a prescription heart medication used to treat heart failure, high blood pressure, and reduced heart function after a heart attack.

Brand names CoregCoreg CR
Drug classes Alpha-adrenergic Blocker
Rx Forms 2
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 2, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 134 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

✓No current FDA shortage listed · checked Oct 4, 2026 🚨Recall on record · 6
Carvedilol at a glance The quick version — the full detail is in the Patient Information Guide below.
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

Carvedilol (Coreg) is a beta-blocker that both slows the heart and relaxes blood vessels. On the market since about 1995 and available as a generic, it is a standard medicine for heart failure and for weakened heart pumping after a heart attack, and it also treats high blood pressure. Most people do well on it, though dizziness and tiredness are common in the first weeks and after each dose increase, usually fading as your body adjusts. Never stop it suddenly or let it run out, because quitting abruptly can trigger serious chest pain, a heart attack or a dangerous heart rhythm.

Clinical pearls

  • Always take it with food, which slows absorption and blunts the dizziness many people feel when standing up.
  • With diabetes, carvedilol can hide the racing heart that warns of low blood sugar, so check glucose closely after dose changes.
  • Amiodarone, digoxin, verapamil and diltiazem can add to its heart-slowing effect, so make sure every prescriber knows you take it.
  • If you take it for heart failure, weigh yourself daily and report sudden weight gain, swelling or new shortness of breath.
How we write & review this content — our editorial policy →
How you get itPrescription only
Comes asTablet, Extended-release capsule
Earliest FDA record1995
Companies listing it with the FDA38
FDA label last updatedJul 31, 2026
FDA’s strongest warning (boxed)None on the label

Patient information guide A plain-language walkthrough of Carvedilol, written from its FDA label.

What Carvedilol is used for

▾

Carvedilol is approved to treat three conditions across its available products:

  • Mild to severe chronic heart failure — all carvedilol products (tablets and extended-release capsules) are indicated, usually used together with diuretics, ACE inhibitors, and digitalis to improve survival and reduce hospitalizations
  • Left ventricular dysfunction after a heart attack — all carvedilol products are used in clinically stable patients whose heart's pumping function is significantly reduced (ejection fraction ≤ 40%), to lower the risk of dying from cardiovascular causes
  • High blood pressure (hypertension) — all carvedilol products are approved for essential hypertension; they can be used alone or combined with other blood pressure medications, especially thiazide-type diuretics

How Carvedilol works

▾

Carvedilol blocks two types of receptors: beta-adrenergic receptors (which slow the heart and reduce its workload) and alpha-1 adrenergic receptors (which relax and widen blood vessels, lowering resistance). This dual action reduces blood pressure, slows a fast heart rate, and over time can improve how well the heart pumps. In heart failure patients, studies showed meaningful improvements in the heart's ejection fraction (pumping efficiency) over weeks to months of treatment.

Carvedilol does not stimulate the receptors it blocks — it simply gets in the way of signals that would otherwise stress the heart and vessels. The exact reason these effects extend survival in heart failure and after heart attacks is not fully established, but the blood pressure and heart rate reductions play an important role.

Carvedilol dosage

▾

Carvedilol comes as a twice-daily tablet and a once-daily extended-release capsule — these are different regimens and are not simply interchangeable on a one-for-one basis. Both forms must be taken with food to slow absorption and reduce dizziness when standing. Your doctor will always start you at a low dose and increase it gradually over weeks, monitoring how you respond. Never adjust or stop your dose on your own.

  • Tablets (Carvedilol, Coreg): taken twice daily; dose is increased over intervals of at least 2 weeks as tolerated
  • Extended-release capsules (Coreg CR, Carvedilol Phosphate): taken once every morning; capsules must be swallowed whole or beads can be sprinkled on cool applesauce if needed — consumed immediately

Dosing details from the FDA-approved label

From the Carvedilol prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

  • Heart failure
    • Start at 10 mg once daily for 2 weeks
    • Patients who tolerate it may have the dose increased to 20 mg, 40 mg, and 80 mg once daily over successive intervals of at least 2 weeks
    • Maintain lower doses if higher doses are not tolerated
    • Maximum: 80 mg once daily
    • Fluid retention should be minimized before initiation; reduce the dose if heart rate is less than 55 beats per minute
  • Left ventricular dysfunction following myocardial infarction
    • Start at 20 mg once daily and increase after 3 to 10 days, based on tolerability, to 40 mg once daily, then to the target dose of 80 mg once daily
    • A lower starting dose of 10 mg once daily may be used and/or up-titration may be slowed if clinically indicated
    • Maximum: 80 mg once daily
    • Start after the patient is hemodynamically stable and fluid retention has been minimized
  • Hypertension
    • Start at 20 mg once daily
    • Maintain for 7 to 14 days, then increase to 40 mg once daily if needed, maintain for 7 to 14 days, then adjust upward to 80 mg once daily if tolerated and needed
    • Maximum: Total daily dose should not exceed 80 mg
    • Use standing systolic pressure about one hour after dosing as a guide; take once daily in the morning with food
  • Switching from immediate-release carvedilol tablets
    • 6.25 mg (3.125 mg twice daily) to 10 mg once daily
    • 12.5 mg (6.25 mg twice daily) to 20 mg once daily
    • 25 mg (12.5 mg twice daily) to 40 mg once daily
    • 50 mg (25 mg twice daily) to 80 mg once daily
    • Subsequent titration to higher doses should be made after an interval of at least 2 weeks
  • Elderly patients or those at increased risk of hypotension, dizziness, or syncope (switching from carvedilol 12.5 mg or 25 mg twice daily)
    • A starting dose of 20 mg or 40 mg once daily, respectively, may be warranted
    • A lower starting dose should be considered when switching from higher doses of immediate-release carvedilol
    • Lower starting dose to reduce the risk of hypotension and syncope
  • Severe hepatic impairment
    • Should not be given to patients with severe hepatic impairment
Read the label’s full dosing text

2 DOSAGE AND ADMINISTRATION Carvedilol phosphate extended-release capsules are intended for once-daily administration. Patients controlled with immediate-release carvedilol tablets alone or in combination with other medications may be switched to carvedilol phosphate extended-release capsules based on the total daily doses shown in Table 1. Table 1. Dosing Conversion Daily Dose of Immediate-Release Carvedilol Tablets Daily Dose of Carvedilol Phosphate Extended-Release Capsules* 6.25 mg (3.125 mg twice daily) 10 mg once daily 12.5 mg (6.25 mg twice daily) 20 mg once daily 25 mg (12.5 mg twice daily) 40 mg once daily 50 mg (25 mg twice daily) 80 mg once daily * When switching from carvedilol 12.5 mg or 25 mg twice daily, a starting dose of carvedilol phosphate extended-release capsules 20 mg or 40 mg once daily, respectively, may be warranted for elderly patients or those at increased risk of hypotension, dizziness, or syncope. Subsequent titration to higher doses should, as appropriate, be made after an interval of at least 2 weeks. Carvedilol phosphate extended-release capsules should be taken once daily in the morning with food. Carvedilol phosphate extended-release capsules should be swallowed as a whole capsule. Carvedilol phosphate extended-release capsules and/or its contents should not be crushed, chewed, or taken in divided doses. Alternative Administration The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce. The applesauce should not be warm because it could affect the modified-release properties of this formulation. The mixture of drug and applesauce should be consumed immediately in its entirety. The drug and applesauce mixture should not be stored for future use. Absorption of the beads sprinkled on other foods has not been tested. Take with food. Do not crush or chew capsules. Individualize dosage and monitor during up-titration. ( 2 ) Heart failure: Start at 10 mg once daily and increase to 20 mg, 40 mg, and then 80 mg once daily over intervals of at least 2 weeks. Maintain lower doses if higher doses are not tolerated. ( 2.1 ) Left ventricular dysfunction following myocardial infarction: Start at 20 mg once daily and increase to 40 mg then 80 mg once daily after intervals of 3 to 10 days. A lower starting dose or slower titration may be used.

Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →

Carvedilol side effects

▾

The most commonly reported side effects with carvedilol include:

Common side effects

  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Low blood pressure (hypotension)
  • Slow heart rate (bradycardia)
  • Diarrhea or nausea
  • Weight gain or fluid buildup
  • High blood sugar (hyperglycemia)
  • Diarrhea, nausea, or vomiting
  • Headache

When to get medical help

  • Call your doctor if your heart rate drops below 55 beats per minute or you feel very faint
  • Seek medical help immediately for sudden worsening of chest pain, especially if you have stopped taking carvedilol — never stop this medication abruptly
  • Contact your doctor if you develop signs of worsening heart failure such as sudden weight gain, swelling, or shortness of breath
  • Seek emergency care if you experience a loss of consciousness (syncope)
  • Tell your doctor right away if you notice worsening kidney function (decreased urination, swelling)
  • Get medical help immediately if you have a severe allergic reaction (hives, facial swelling, difficulty breathing)

Call your doctor right away if you faint, your pulse drops very low, your breathing worsens, or you notice sudden swelling — these can be signs of more serious reactions that need prompt attention.

Carvedilol warnings and precautions

▾
  • Never stop carvedilol abruptly — in people with coronary artery disease, sudden discontinuation can trigger severe chest pain, heart attack, or dangerous heart rhythms. Always taper under medical supervision over 1 to 2 weeks.
  • Low blood pressure and dizziness are most likely early in treatment or with dose increases — avoid driving or hazardous activities during these periods; taking carvedilol with food helps.
  • Slow heart rate (bradycardia) — if your pulse falls below 55 beats per minute, your dose needs to be reduced; tell your doctor promptly.
  • Diabetes: carvedilol can mask the rapid heartbeat that warns you of low blood sugar, and it may worsen blood sugar control in people with heart failure — monitor glucose closely whenever your dose changes.
  • Asthma and breathing problems: carvedilol is contraindicated in bronchial asthma; it must be used with great caution (if at all) in chronic bronchitis or emphysema, at the lowest effective dose.
  • Worsening heart failure or kidney function can occasionally occur early in treatment — report sudden weight gain, increasing swelling, or decreased urination to your doctor without delay.
  • Surgery: tell your surgeon and anesthesiologist you take carvedilol — it can affect how your heart responds to anesthesia.
  • Cataract surgery: carvedilol's alpha-blocking activity has been linked to a complication called Intraoperative Floppy Iris Syndrome (IFIS) — always inform your eye surgeon before any eye procedure.

Carvedilol interactions

▾

Carvedilol interacts with several commonly used medications — always share your full medication list with your pharmacist and prescriber:

  • Digoxin: carvedilol raises digoxin blood levels by about 15% and both drugs slow heart conduction — digoxin levels need extra monitoring
  • Insulin and oral diabetes drugs: carvedilol enhances their blood-sugar-lowering effect and masks the fast heartbeat warning of low blood sugar — monitor glucose regularly
  • Amiodarone: raises carvedilol levels significantly and further slows the heart — watch for very slow pulse or heart block
  • Clonidine, reserpine, or MAO inhibitors: can combine with carvedilol to cause dangerously low blood pressure or very slow heart rate
  • Verapamil or diltiazem (calcium channel blockers): can cause conduction disturbances — ECG and blood pressure monitoring is recommended
  • Rifampin (antibiotic): reduces carvedilol levels by about 70%, greatly reducing its effectiveness
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine, propafenone): expected to raise carvedilol levels and increase dizziness risk
  • Cyclosporine (immune suppressant): carvedilol can raise cyclosporine levels — dose adjustments and monitoring may be needed

Interactions listed in the FDA-approved label

From the Carvedilol prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • CYP2D6 inhibitors (quinidine, fluoxetine, paroxetine, propafenone): Not studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol; poor 2D6 metabolizers had a higher rate of dizziness during up-titration.
  • Hypotensive agents (reserpine, monoamine oxidase inhibitors): May increase the risk of hypotension and/or severe bradycardia. Observe closely for signs of hypotension and/or severe bradycardia.
  • Clonidine: Concomitant administration with a beta-blocker may cause hypotension and bradycardia. When ending concomitant treatment, discontinue the beta-blocker first; clonidine can then be discontinued several days later by gradually decreasing the dosage.
  • Cyclosporine: Modest increases in mean trough cyclosporine concentrations were observed; in about 30% of subjects the cyclosporine dose had to be reduced. Monitor cyclosporine concentrations closely after initiation of carvedilol and adjust the cyclosporine dose as appropriate.
  • Digitalis glycosides (digoxin): Both slow atrioventricular conduction and decrease heart rate, increasing the risk of bradycardia; digoxin concentrations are increased by about 15%. Increased monitoring of digoxin is recommended when initiating, adjusting, or discontinuing carvedilol.
  • Rifampin: Reduced plasma concentrations of carvedilol by about 70%.
  • Cimetidine: Increased area under the curve (AUC) by about 30% but caused no change in Cmax.
  • Amiodarone or other CYP2C9 inhibitors such as fluconazole: Amiodarone increased concentrations of the S(-) enantiomer of carvedilol by at least 2-fold and may enhance beta-blocking activity, further slowing heart rate or cardiac conduction. Observe for signs of bradycardia or heart block, particularly when one agent is added to pre-existing treatment with the other.
  • Calcium channel blockers (verapamil or diltiazem type): Conduction disturbance (rarely with hemodynamic compromise) has been observed with diltiazem. Monitor ECG and blood pressure.
  • Insulin or oral hypoglycemics: Beta-blockers may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics. Regular monitoring of blood glucose is recommended.
Read the label’s full interactions text

7 DRUG INTERACTIONS CYP P450 2D6 enzyme inhibitors may increase and rifampin may decrease carvedilol levels. ( 7.1 , 7.5 ) Hypotensive agents (e.g., reserpine, MAO inhibitors, clonidine) may increase the risk of hypotension and/or severe bradycardia. ( 7.2 ) Cyclosporine or digoxin levels may increase. ( 7.3 , 7.4 ) Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia. ( 7.4 ) Amiodarone may increase carvedilol levels resulting in further slowing of the heart rate or cardiac conduction. ( 7.6 ) Verapamil- or diltiazem-type calcium channel blockers may affect ECG and/or blood pressure. ( 7.7 ) Insulin and oral hypoglycemics action may be enhanced. ( 7.8 ) 7.1 CYP2D6 Inhibitors and Poor Metabolizers Interactions of carvedilol with potent inhibitors of CYP2D6 isoenzyme (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol [see Clinical Pharmacology (12.3) ] . Retrospective analysis of side effects in clinical trials showed that poor 2D6 metabolizers had a higher rate of dizziness during up-titration, presumably resulting from vasodilating effects of the higher concentrations of the alpha-blocking R(+) enantiomer. 7.2 Hypotensive Agents Patients taking a beta-blocker and a drug that can deplete catecholamines (e.g., reserpine and monoamine oxidase inhibitors) should be observed closely for signs of hypotension and/or severe bradycardia. Concomitant administration of clonidine with a beta-blocker may cause hypotension and bradycardia. When concomitant treatment with a beta-blocker and clonidine is to be terminated, the beta-blocker should be discontinued first. Clonidine therapy can then be discontinued several days later by gradually decreasing the dosage.

Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

🌿211 supplements and herbs with documented Carvedilol interactions, ranked by severity Check Carvedilol against a supplement or herb →

Before taking Carvedilol

▾
  • Bronchial asthma or bronchospasm: carvedilol is contraindicated — deaths from severe bronchospasm have been reported
  • Severe heart block, sick sinus syndrome, or severe bradycardia without a pacemaker: do not use
  • Cardiogenic shock or decompensated heart failure requiring IV heart medications: do not start carvedilol until stabilized
  • Severe liver disease: carvedilol is contraindicated
  • History of serious allergic reactions (e.g., Stevens-Johnson syndrome, anaphylaxis, angioedema) to carvedilol: do not use
  • Pregnancy: use in the third trimester may cause low blood pressure, slow heart rate, low blood sugar, and breathing problems in the newborn — discuss risks and benefits with your doctor
  • Breastfeeding: it is unknown whether carvedilol passes into human breast milk — weigh benefits against potential risks with your doctor
  • Children under 18: effectiveness has not been established
  • Older adults: may be more prone to dizziness and low blood pressure, especially when switching from tablets to extended-release capsules at higher doses — a lower starting dose is recommended
  • Diabetes: blood glucose must be monitored closely when starting, changing, or stopping carvedilol
  • Peripheral vascular disease or Prinzmetal's variant angina: use with caution — beta-blockade can worsen symptoms

Carvedilol overdose

▾

Taking too much carvedilol can cause severely low blood pressure, very slow heart rate, heart failure, cardiogenic shock, and in serious cases, cardiac arrest. Breathing problems, bronchospasm, vomiting, loss of consciousness, and seizures may also occur. If an overdose is suspected, call 911 or poison control immediately — do not wait for symptoms to worsen. Because carvedilol stays in the body for 7 to 10 hours, treatment and monitoring may need to continue for an extended period.

What Carvedilol does in the body

▾

Carvedilol lowers blood pressure and heart rate by blocking both beta and alpha-1 receptors. Its blood-pressure-lowering effect begins within about 30 minutes of a dose (from alpha-1 blockade) and significant heart-rate slowing is usually seen within 1 hour (from beta-blockade). In people with heart failure, longer-term use has been shown to improve the heart's ejection fraction — a measure of how much blood the heart pumps with each beat — and to reduce pressures inside the heart. Because it lowers blood pressure more in the standing position than lying down, dizziness when standing up (orthostatic hypotension) can occur, especially early in treatment.

How your body processes Carvedilol

▾

Carvedilol is absorbed quickly after an oral dose but undergoes significant first-pass metabolism in the liver, meaning only about 25–35% of the tablet dose reaches the bloodstream unchanged. The extended-release capsule form reaches peak blood levels more slowly — around 5 hours after dosing — but delivers equivalent overall drug exposure to the tablet when both are taken with food. Carvedilol is heavily broken down by liver enzymes (mainly CYP2D6 and CYP2C9) into active and inactive byproducts, which are eliminated primarily through bile and stool. The drug's half-life (the time for blood levels to fall by half) is typically 7 to 10 hours, and it is more than 98% bound to proteins in the blood.

How to store Carvedilol

▾

Store at 20° to 25°C (68° to 77°F). DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

211

Supplements & herbs that interact with Carvedilol

211 supplements and herbal products have documented interactions with Carvedilol in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 6
  • Moderate · 171
  • Minor · 34
ACTIVATED CHARCOAL Major AMERICAN HELLEBORE Major AMERICAN MISTLETOE Major GRAPEFRUIT Major INDIAN SNAKEROOT Major TYRAMINE Major 1,3-DMAA Moderate ACACIA RIGIDULA Moderate +203 more
Every supplement checked against Carvedilol — ranked by severity The full interaction hub: 6 major · 171 moderate · 34 minor · every one linked to its full report. Check Carvedilol against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

1

Nutrient depletion considerations

Carvedilol has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

COENZYME Q10 Insufficient Evidence
See the full Carvedilol nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

Carvedilol: pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Carvedilol — the kind of thing our pharmacy team would talk through with you at the counter.

What is carvedilol actually doing for my heart?

▾
Carvedilol works in two ways at once. It blocks beta receptors, which slows your heart rate and reduces how hard your heart has to work. It also blocks alpha-1 receptors, which relaxes and widens your blood vessels so blood can flow more easily. Over time, especially in heart failure, this combination can actually improve how efficiently your heart pumps. It's not a quick fix — the benefits build up over weeks and months of consistent use.

Why do I have to take it with food? Does it matter?

▾
Yes, it really does matter. Taking carvedilol with food slows down how fast it's absorbed into your bloodstream. That slower absorption significantly reduces the chance of feeling dizzy or faint when you stand up — a side effect called orthostatic hypotension. For the extended-release capsules (like Coreg CR), taking them with food also affects how much of the drug you absorb, so it's especially important not to skip the meal.

I felt dizzy and lightheaded after my first dose — is that normal?

▾
Very common, especially in the first few weeks or whenever your dose is increased. Carvedilol lowers blood pressure, and your body needs a little time to adjust. The dizziness usually hits hardest within the first hour after taking it. During this adjustment period, take it slow when you stand up, and avoid driving or anything risky until you know how you feel. If you actually faint or your heart rate drops very low, call your doctor right away — that's a signal the dose may need adjusting.

Can I just stop taking carvedilol if I feel like it's not helping or if I run out?

▾
Please don't stop suddenly, even if you feel fine or run out of pills. If you have coronary artery disease — even if you didn't know it — stopping a beta-blocker abruptly can trigger severe chest pain, a heart attack, or dangerous heart rhythms. If you need to stop for any reason, your doctor should taper the dose slowly over 1 to 2 weeks. If you're running low on medication, contact your pharmacy or prescriber right away so there's no gap.

I have diabetes — is there anything special I need to know about taking carvedilol?

▾
Yes, this is important. Carvedilol can hide one of the key warning signs of low blood sugar — a racing heart. So if your blood sugar drops, you might not get that usual alert. You should monitor your glucose more closely, especially when you first start carvedilol or when your dose changes. Also, if you have heart failure and diabetes, carvedilol can sometimes make blood sugar harder to control at first. Let your doctor know so they can adjust your diabetes treatment if needed.

I'm pregnant — is it safe for me to keep taking carvedilol?

▾
This is a conversation to have with your doctor as soon as possible. Using beta-blockers like carvedilol in the third trimester of pregnancy can affect the newborn — potentially causing low blood pressure, slow heart rate, low blood sugar, or breathing problems at birth. At the same time, untreated high blood pressure in pregnancy carries its own serious risks. Your doctor will weigh the benefits and risks for your specific situation. Don't stop on your own — always get guidance first.

Is Carvedilol available over the counter?

▾
No. Carvedilol is a prescription medicine: every Carvedilol product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was Carvedilol first available?

▾
The earliest FDA record we hold for Carvedilol is from 1995: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Carvedilol was first used.

Who makes Carvedilol?

▾
38 companies currently list Carvedilol products in the FDA's NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions, Proficient Rx LP. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Carvedilol on HelloPharmacist

📊Carvedilol supplement interactions211 checked — ranked by severity 🌿Drug & Supplement CheckerCarvedilol vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Carvedilol NDCs & costs 🅰️Browse Drugs A–ZLook up any medication
Detailed data & references for Carvedilol Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Carvedilol forms and strengths (how it comes)

Carvedilol is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Tablet

By mouth
Brands Coreg
How this form is used
What it may be used for
  • Carvedilol tablets and Coreg tablets are used to treat mild to severe chronic heart failure, usually alongside diuretics, ACE inhibitors, and digitalis
  • Carvedilol tablets and Coreg tablets are used to reduce the risk of cardiovascular death in clinically stable patients with reduced heart function after a heart attack
  • Carvedilol tablets and Coreg tablets are used to treat high blood pressure (hypertension), alone or with other blood pressure medications
Important instructions
  • Carvedilol tablets and Coreg tablets should always be taken with food to reduce the risk of dizziness when standing
  • Coreg tablets are typically taken twice daily — your doctor will start you at a low dose and gradually increase it over at least two-week intervals
  • Coreg dose increases should be paused if you experience worsening heart failure symptoms, fluid buildup, or significant dizziness until your condition is stable
  • Carvedilol tablets are taken twice daily; your doctor will individualize your dose and monitor you closely during any dose increases
Available strengths 4 strengths
3.125 mg 6.25 mg 12.5 mg 25 mg
378 FDA-listed product records ⓘ

Extended-release capsule

By mouth
Brands Coreg CR
How this form is used
What it may be used for
  • Carvedilol Phosphate extended-release capsules and Coreg CR are used to treat mild to severe chronic heart failure, usually alongside diuretics, ACE inhibitors, and digitalis
  • Carvedilol Phosphate extended-release capsules and Coreg CR are used to reduce cardiovascular mortality in stable patients with reduced heart function after a heart attack
  • Carvedilol Phosphate extended-release capsules and Coreg CR are used to treat high blood pressure (hypertension), alone or with other blood pressure medications
Important instructions
  • Coreg CR and Carvedilol Phosphate extended-release capsules are taken once daily in the morning with food
  • Coreg CR and Carvedilol Phosphate extended-release capsules must be swallowed whole — do not crush, chew, or split them
  • If you have difficulty swallowing, Coreg CR and Carvedilol Phosphate extended-release capsules may be carefully opened and the beads sprinkled on a spoonful of cool (not warm) applesauce — consume the mixture immediately and do not store it
  • Coreg CR: older adults switching from the highest doses of the immediate-release tablet should start at a lower extended-release dose to reduce the risk of dizziness, low blood pressure, or fainting
Available strengths 4 strengths
10 mg 20 mg 40 mg 80 mg
65 FDA-listed product records ⓘ

Carvedilol on the U.S. market: products, makers and brands

How Carvedilol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

38 companies list 206 Carvedilol product records with the FDA, mostly as tablet, extended-release capsule; the earliest marketing or approval year on record is 1995. Brand names on the directory include Coreg, Coreg CR; the rest are generics.

2
Dose forms ⓘ
38
Labelers (makers, repackagers, distributors)
4
Brand names
206
FDA-listed product records ⓘ
1995
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (30) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack10%
A-S Medication Solutions8%
Proficient Rx LP6%
NuCare Pharmaceuticals,Inc.5%
Golden State Medical Supply, Inc.4%
PD-Rx Pharmaceuticals, Inc.4%
Other makers63%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Carvedilol is used (Medicaid data)

A general measure of how commonly Carvedilol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Carvedilol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

2,202,041
Medicaid prescriptions filled (Q1–Q4 2025)
$23M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Carvedilol prescribed? Of the 1,601 medications we measure, Carvedilol ranks #101 by Medicaid prescriptions — more than 94% of them.

Where Carvedilol ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #101 of 1,601
#96 Insulin Lispro Injecti... 2,318,237 Rx #97 Methocarbamol 2,261,221 Rx #98 Tizanidine 2,254,693 Rx #99 Cefdinir 2,236,722 Rx #100 Sulfamethoxazole / Tri... 2,217,156 Rx #101 Carvedilol 2,202,041 Rx #102 Nystatin 2,190,507 Rx #103 Benzonatate 2,171,868 Rx #104 Apixaban 2,151,899 Rx #105 Lidocaine Transdermal... 2,146,915 Rx #106 Baclofen 2,144,009 Rx

Utilization by Carvedilol product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 25 mg oral tablet is the most-dispensed Carvedilol product — about 30% of these Medicaid prescriptions.

carvedilol 25 MG Oral Tablet Most dispensed

666,213 Medicaid prescriptions (Q1–Q4 2025) 30% of Carvedilol prescriptions shown $7.1M gross reimbursement (before rebates) ≈ $11 per prescription (gross)

Summed across the 17 of 196 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200033

carvedilol 12.5 MG Oral Tablet

562,371 Medicaid prescriptions (Q1–Q4 2025) 26% of Carvedilol prescriptions shown $5.5M gross reimbursement (before rebates) ≈ $9.72 per prescription (gross)

Summed across the 17 of 181 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200032

carvedilol 6.25 MG Oral Tablet

559,053 Medicaid prescriptions (Q1–Q4 2025) 25% of Carvedilol prescriptions shown $5.3M gross reimbursement (before rebates) ≈ $9.46 per prescription (gross)

Summed across the 17 of 209 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200031

carvedilol 3.125 MG Oral Tablet

409,817 Medicaid prescriptions (Q1–Q4 2025) 19% of Carvedilol prescriptions shown $4M gross reimbursement (before rebates) ≈ $9.65 per prescription (gross)

Summed across the 16 of 169 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 686924

24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule

1,453 Medicaid prescriptions (Q1–Q4 2025) <1% of Carvedilol prescriptions shown $365,150 gross reimbursement (before rebates) ≈ $251 per prescription (gross)

Summed across the 3 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860516

24 HR carvedilol phosphate 40 MG Extended Release Oral Capsule

1,349 Medicaid prescriptions (Q1–Q4 2025) <1% of Carvedilol prescriptions shown $353,817 gross reimbursement (before rebates) ≈ $262 per prescription (gross)

Summed across the 3 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860522

24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule

1,129 Medicaid prescriptions (Q1–Q4 2025) <1% of Carvedilol prescriptions shown $319,669 gross reimbursement (before rebates) ≈ $283 per prescription (gross)

Summed across the 3 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860510

24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule

656 Medicaid prescriptions (Q1–Q4 2025) <1% of Carvedilol prescriptions shown $184,326 gross reimbursement (before rebates) ≈ $281 per prescription (gross)

Summed across the 3 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860532

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Carvedilol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 79 of 847 listed Carvedilol NDCs with Medicaid activity.

Compare Carvedilol products

A representative set of FDA-listed product records for Carvedilol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 99 of 206 products — FDA National Drug Code Directory. See every product, package size and price: browse all 206 Carvedilol NDCs →

Carvedilol side effects reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Carvedilol — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Carvedilol are fatigue, dyspnoea, diarrhoea; about 69% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

137,028
Reports mentioning it
69%
Reported as serious
12
Distinct effects shown
Most reported effects
Fatigue
9,142
Dyspnoea
8,542
Diarrhoea
7,251
Dizziness
7,212
Nausea
6,831
Death
5,872
Hypotension
5,782
Asthenia
5,543
Fall
4,520
Cardiac Failure Congestive
4,505
Age groups
Elderly · 13,019Adult · 7,903Neonate · 73Child · 51Adolescent · 46Infant · 19

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Carvedilol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Carvedilol FDA approval history

How Carvedilol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Carvedilol was first approved by the FDA in 1995 (Brand: COREG · Waylis Therap); the first generic version was approved in 2007. It remains available in U.S. pharmacies today.

1995
Brand approved
Brand: COREG · Waylis Therap
2007
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Carvedilol recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 8 Carvedilol recalls since July 2021, covering 15 product listings. Six of them are still ongoing or began in the last six months and are listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Aug 20, 2025 · The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
  • Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61 Lots: Lot #: T05693, Exp. Date 03/2026 FDA record D-0594-2025 →
Ongoing Class II Aug 7, 2025 · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
  • Carvedilol Tablets, USP, 25 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, Mah… Lots: Lot#:19243104, Expires: 7/31/2026. FDA record D-0579-2025 →
  • Carvedilol Tablets, USP, 12.5 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, M… Lots: Lot#:19243202, Exp: 7/31/2026. FDA record D-0578-2025 →
  • Carvedilol Tablets, USP, 3.125 mg, Packaged as: a)500-count bottle, NDC 68462-162-05; b) 100-count bottle, NDC 68462-162-01; Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Go… Lots: Lot#: a)19242274, 19242275, 19242272, Exp: 5/31/20; b) 19242272, Exp: 5/31/2026 FDA record D-0577-2025 →
Ongoing Class II Aug 6, 2025 · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
  • Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, I… Lots: Lot #: 17241213, 17241215, 17241224, Exp. Date 06/2026 FDA record D-0588-2025 →
  • Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775,… Lots: Lot #: 17241257, 17241258, 17241279, Exp. Date 06/2026 FDA record D-0587-2025 →
Ongoing Class II Mar 13, 2025 · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
  • Carvedilol Tablets, USP 12.5 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc.… Lots: Lot # 17240238, exp. date Jan-26 17240243, exp. date Jan-26 17240245, exp. date Jan-26 17240248, exp. date Jan-26 FDA record D-0336-2025 →
Ongoing Class II Feb 28, 2025 · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
  • Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05. Lots: Lot, expiry: Lots 19231107, 19231114, 19231152, Exp Feb-25; Lot 19234866, Exp Jan-26 FDA record D-0451-2025 →
  • Carvedilol Tablets USP 12.5 mg, 500-Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC: 68462-164-05 Lots: Lot, Exp: Lots 19231899, 19231922, 19231927, 19231967, 19231979, Exp Apr-25; Lots 19232226, 19232234, 19232265, 1923227,1 Exp May-25; Lots 19232758, 19232759, 19232762, 19232788, Exp Jun-25 FDA record D-0450-2025 →
  • Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pha… Lots: [100-Count Bottles] Lot 19231618, exp Mar-25; 19232064, exp Apr-25; 19232324, May-25; 19233369, Exp Jul-25; Lot 19234162, Exp Sep-25; Lot 19240543, Exp Jan-26 [500-Count Bottles] Lots 19231174, 19231199, 19231164, Exp Feb-25, 19231517,1923… FDA record D-0449-2025 →
  • Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01), b.) 500-count bottle (NDC 68462-162-05), Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glen… Lots: [100-Count Bottles] Lot 19231450, Exp Mar-25, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lot 19240280, Exp DEC-25 [500-Count Bottles] Lot 19231450, 19231464, 19231471, 19231493, Exp Mar-25, 19232083, 19232103 Exp Apr-25, 19232658, Exp… FDA record D-0448-2025 →
Ongoing Class II Jan 22, 2025 · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
  • Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01, Manufactured for Glenmark Pharmaceuticals, NJ. Lots: Lot numbers: a) 17230658, Exp.: 02/2025; 17230814,17230822, Exp.: 03/2025; 17231004,17231009,17231022, Exp.: 04/2025; 17231393,17231392, Exp.: 05/2025; 17231538, 17231541,17231542, Exp.: 06/2025; 17231710,17231718,17231721,17231722,1723173… FDA record D-0216-2025 →
  • Carvedilol Tablets, USP, 25 mg, Rx only, a)500 Tablets, NDC 68462-165-05; b) 100 Tablets, NDC 68462-165-01, Manufactured for Glenmark Pharmaceuticals, NJ. Lots: Lot numbers: a) 17230500, 17230509,17230526,17230546,17230551,17230603,17230628, 17230642,17230645,17230681, Exp.:02/2025; 17230829,17230832,17230854, 17230864,17230874,17230876,17230889,17230894, Exp.: 03/2025; 17230960, 17230964,17230976… FDA record D-0215-2025 →
Class III Nov 15, 2021 · Terminated · Aurobindo Pharma USA Inc.
Failed Impurities/Degradation Specifications
  • Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by: Aurobindo Pharma USA Inc., 279 Princeton-Hightstown Road, East Windsor, NJ, 08520, Made in India, NDC 65862-143-05 Lots: Batch QG0619030-A, exp 11/2022 FDA record D-0263-2022 →
Class II Aug 13, 2021 · Terminated · Zydus Pharmaceuticals (USA) Inc
Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle
  • Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05 Lots: Z006279, exp 12/31/2022 FDA record D-0753-2021 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Carvedilol RxCUI 20352 2 dose forms · 8 strengths
  2. Dose form (SCDF) Oral Tablet RxCUI 371296 In current FDA listings
    Clinical drug / strength (SCD) 3.125 MG RxCUI 686924 6.25 MG RxCUI 200031 12.5 MG RxCUI 200032 25 MG RxCUI 200033

Look up RxCUI 20352 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

💵 What Carvedilol costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

FormStrengthPharmacy acquisition benchmark
Tablet, Film Coated · Oral 25 mg $0.032 per tablet NDC details & price history
Tablet, Film Coated · Oral 6.25 mg $0.018 per tablet NDC details & price history
Tablet, Film Coated · Oral 12.5 mg $0.022 per tablet NDC details & price history
Tablet, Film Coated · Oral 3.125 mg $0.017 per tablet NDC details & price history
Capsule, Extended Release · Oral 10 mg $6.52 per capsule NDC details & price history
Capsule, Extended Release · Oral 40 mg $6.38 per capsule NDC details & price history
Capsule, Extended Release · Oral 80 mg $5.79 per capsule NDC details & price history
Capsule, Extended Release · Oral 20 mg $6.74 per capsule NDC details & price history
Tablet, Film Coated 25 mg $0.032 per tablet NDC details & price history
Tablet, Film Coated 12.5 mg $0.022 per tablet NDC details & price history
Why show this? Your out-of-pocket cost depends on insurance, pharmacy markup, and discounts — but the acquisition benchmark tells you whether the medication itself is inexpensive or costly, which strengths cost more per dose, and whether a cash-price quote is in a reasonable range. Each row links to the NDC-level record with its full price history.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Carvedilol brand names

Carvedilol is sold under 2 brand names in the FDA directory — Coreg, Coreg CR. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Coreg Coreg CR

Who makes Carvedilol: manufacturers and labelers

38 companies list Carvedilol products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, A-S Medication Solutions, Proficient Rx LP. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 21 A-S Medication Solutions 17 Proficient Rx LP 12 NuCare Pharmaceuticals,Inc. 10 Golden State Medical Supply, Inc. 8 PD-Rx Pharmaceuticals, Inc. 8 Waylis Therapeutics LLC 8 Northwind Health Company, LLC 7 Remedyrepack Inc. 7 Aphena Pharma Solutions - Tennessee, LLC 5 Coupler LLC 5 Direct_Rx 5 Preferred Pharmaceuticals Inc. 5 Advagen Pharma Limited 4 Advagen Pharma Ltd 4 Amneal Pharmaceuticals NY LLC 4 Amneal Pharmaceuticals of New York LLC 4 Aurobindo Pharma Limited 4 AvKARE 4 BluePoint Laboratories 4 Cardinal Health 107, LLC 4 Dr. Reddy's Laboratories Limited 4 Glenmark Pharmaceuticals Inc., USA 4 Major Pharmaceuticals 4

…and 14 more on the FDA NDC directory.

Carvedilol drug class (RxNorm)

Carvedilol belongs to the alpha-Adrenergic Blocker class.

Pharmacologic class alpha-Adrenergic Blocker, beta-Adrenergic Blocker
Drug family (ATC) Alpha and beta blocking agents
How it works Adrenergic alpha-Antagonists, Adrenergic beta1-Antagonists, Adrenergic beta2-Antagonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Carvedilol page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jul 31, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Carvedilol.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Carvedilol after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
134
Finished products in the current FDA directory
206
Companies listing them (makers, repackagers, distributors)
38
FDA labeler codes behind them ⓘ
39
Linked representative label ⓘ
Waylis Therapeutics LLC
Linked label effective
Jul 31, 2026
Composite sections available
23
Linked SPL Set ID
07c619c6-4a0c-445e-94fa-664a54f68a39
Linked SPL Document ID
514a36dd-5646-48b3-99cc-1457af6cb7d8
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Waylis Therapeutics LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →